Quarterly report pursuant to Section 13 or 15(d)

Equity Incentive Plan (Tables)

v3.22.2.2
Equity Incentive Plan (Tables)
 9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of share-based compensation expense
    Three Months Ended
September 30,
(unaudited)		     Nine Months Ended
September 30,
(unaudited)		  
(in thousands)   2022     2021     2022     2021  
General and administrative   $ 320     $ 258     $ 974     $ 649  
Sales and marketing     50       31       120       88  
Research and development     85       68       231       181  
Cost of revenues     22       14       67       76  
    $ 477     $ 371     $ 1,392     $ 994  

 
Schedule of fair value of option grants weighted average assumptions
    Nine Months Ended
September 30,
(unaudited)		  
    2022     2021  
Expected term (in years)     5.9       5.8  
Expected Volatility     54.6 %     54.4 %
Risk-free rate     2.0 %     0.8 %
Dividend rate    
—
      
—
  

 
Schedule of stock option activity
    Number of
Shares
under
Option Plan		     Weighted-
Average
Exercise
Price per
Option		     Weighted-
Average
Remaining
Contractual
Term
(in years)		  
Outstanding at December 31, 2021     6,583,381     $ 1.78       8.0  
Granted     1,743,474     $ 2.36          
Exercised     (51,602 )   $ 0.75          
Forfeited and expired     (156,365 )   $ 2.83          
Outstanding at September 30, 2022     8,118,888     $ 1.89       7.7  
Exercisable at September 30, 2022     4,816,549     $ 1.38       7.3  
Vested and expected to vest at September 30, 2022     8,118,888     $ 1.89       7.7